This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 Apr 4;285(13):1760-1.

doi: 10.1001/jama.285.13.1760.

Neuroprotection in acute ischemic stroke

F Plum

PMID: 11277833
DOI: 10.1001/jama.285.13.1760

Editorial

Neuroprotection in acute ischemic stroke

F Plum. JAMA. 2001.

. 2001 Apr 4;285(13):1760-1.

doi: 10.1001/jama.285.13.1760.

Author

F Plum

PMID: 11277833
DOI: 10.1001/jama.285.13.1760

No abstract available

PubMed Disclaimer

Comment on

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.
Sacco RL, DeRosa JT, Haley EC Jr, Levin B, Ordronneau P, Phillips SJ, Rundek T, Snipes RG, Thompson JL; Glycine Antagonist in Neuroprotection Americas Investigators. Sacco RL, et al. JAMA. 2001 Apr 4;285(13):1719-28. doi: 10.1001/jama.285.13.1719. JAMA. 2001. PMID: 11277826 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information